Dossier
Orzeyful
Coverage of Orzeyful in the Nexus archive.
- STAT+: Takeda’s narcolepsy drug approved by the FDA, seen as a boon for new class of treatments
The FDA approved Takeda's Orzeyful, an orexin receptor agonist for narcolepsy type 1, marking a new class of treatments for sleep disorders. The drug demonstrated improved wakefulness and reduced symptoms compared to existing therapies in Phase 3 trials.